Connect with us
deals book
Polaris bank
Access bank

Business News

ACCI set to explore $3 trillion Halal economy

ACCI and other investment stakeholders are set to explore investment opportunities in the global Halal economy currently pegged at $3 trillion.



ACCI set to explore $3 trillion Halal economy

The Abuja Chamber of Commerce and Industry (ACCI) and other investment stakeholders are set to explore investment opportunities in the global Halal economy currently pegged at $3 trillion.

The ACCI President, Adetokunbo Kayode, made this known during the pre-event briefing on the forthcoming Halal Expo Nigeria 2020.

According to him, Nigeria needs to keep pace with the global trends in the Halal economy as it has lots of products and partnerships that can stimulate investment for economic growth in the country.

He said the chamber was ready to collaborate with willing stakeholders and investors to explore opportunities in the Halal economy for wealth creation. This, he said, was the reason for the forthcoming Halal Expo.

[READ MORE: Chapel Hill Denham raises N17.85 billion via NIDF series 6)

Kayode noted that Nigeria was at a vantage position to explore opportunities in the Halal economy, which spreads across pharmaceuticals, food industry, finance and other sectors.

“We are 200 million people and we need to expand our doors and explore global opportunities. For instance, Halal beef is exported globally and it is healthy unlike most often what we get here when people carry meat on motorcycles, trycycles and on their shoulders, which is unhealthy,” Kayode said.

He noted that the initiative and the forthcoming Halal Expo would ensure financial intermediation for many Nigerians since they offer opportunity through interest-free financial management and risk-sharing.

“This is one out of many opportunities that Halal provides for investors since we are even having increased demands for goat meat from our African neighbours,” he added.

Ruth Okwumbu has a MSc. and BSc. in Mass Communication from the University of Nigeria, Nsukka, and Delta state university respectively. Prior to her role as analyst at Nairametrics, she had a progressive six year writing career.As a Business Analyst with Narametrics, she focuses on profiles of top business executives, founders, startups and the drama surrounding their successes and challenges. You may contact her via [email protected]

Click to comment

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.


Covid-19: WHO approves China’s Sinopharm vaccine

WHO has announced the approval of China’s Sinopharm vaccine for Covid-19 vaccination.



Covid-19: First world nations oppose waiving intellectual rights for vaccine development

The World Health Organization (WHO) has announced the approval of China’s Sinopharm vaccine for Covid-19 vaccination.  The vaccine is reported to have 79% efficacy against covid.

This was disclosed today in a report by Reuters. The vaccine would also be the second Chinese-made vaccine after Sinovac vaccine and would be the first developed outside Europe and North America to receive WHO accreditation.

“This expands the list of COVID-19 vaccines that COVAX can buy, and gives countries confidence to expedite their own regulatory approval, and to import and administer a vaccine,” WHO Director-General, Tedros Adhanom Ghebreyesus said.

The WHO added that the easy storage requirements make it highly suitable for low-resource settings.

“Its easy storage requirements make it highly suitable for low-resource settings,” a WHO statement said while also disclosing that the vaccine has been approved for people above the age of 18 to receive two shots.

“On the basis of all available evidence, WHO recommends the vaccine for adults 18 years and older, in a two-dose schedule with a spacing of three to four weeks,” the statement added.

The vaccine was created by Beijing Biological Products Institute, a subsidiary of Sinopharm subsidiary China National Biotec Group, with an efficacy of 79% for all age groups.

The WHO however, admitted that few older adults (over 60 years) were enrolled in clinical trials, so efficacy could not be estimated in this age group.


In case you missed it

The quest for vaccine efficiency got a major boost earlier this week as Nairametrics reported that the United States government announced that it supports the waiver of Intellectual Property Protections on Covid-19 vaccine development, in a bid to boost the fight against the pandemic, and says it will participate in the Okonjo-Iweala-led WTO negotiation to make it happen.

Continue Reading


“Mama Taraba”, Former minister and senator, Aisha Al-Hassan is dead

Ex-Women Affairs minister, Aisha Jummai Al-Hassan, popularly known as Mama Taraba is dead



A former Minister for Women Affairs and ex-Governorship Candidate in Taraba State, Aisha Jummai Al-Hassan, popularly known as Mama Taraba is dead.

According to media reports she died in a hospital on Friday in Cairo, Egypt at the age of 61.

Al-Hassan, who was a former senator of the Federal Republic of Nigeria from Taraba North Senatorial District, was the All Progressive Congress (APC) Governorship Candidate for Taraba in the 2015 general elections.

READ: Abba Kyari’s last letter to President Buhari

She later contested for the same seat on the platform of the United Democratic Party in the 2019 general elections after resigning from APC and as a minister in the administration of President Muhammadu Buhari on July 27, 2018.

The former senator was born on the 16th of September, 1959 in Jalingo, Taraba State, to Alhaji Abubakar Ibrahim, Sarkin Ayukan Muri.

READ: Chad’s President Deby dies of injuries suffered on the frontlines, as son takes over

Aisha Jummai Al-Hassan attended Muhammed Nya Primary School, Jalingo and LEA Primary School, Tudun Wada, Kaduna before proceeding to Saint Faith College (now GGSS) Kawo Kaduna where she studied between January 1973 and June 1977.


Details later…

Continue Reading


Nairametrics | Company Earnings

Access our Live Feed portal for the latest company earnings as they drop.